Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices
Market Cap
$448.80 Million
CN¥3.29 Billion CNY
Market Cap Rank
#15764 Global
#4200 in China
Share Price
CN¥27.17
Change (1 day)
+6.13%
52-Week Range
CN¥15.46 - CN¥40.33
All Time High
CN¥64.43
About

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly activ… Read more

Zhejiang Tailin Bioengineering Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.22%

Zhejiang Tailin Bioengineering Co Ltd (300813) has an Asset Resilience Ratio of 0.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥2.10 Million
Cash + Short-term Investments
Total Assets
CN¥934.06 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2021)

This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥2.10 Million 0.22%
Total Liquid Assets CN¥2.10 Million 0.22%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Tailin Bioengineering Co Ltd maintains only 0.22% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Tailin Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Tailin Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Zhejiang Tailin Bioengineering Co Ltd (2021–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Tailin Bioengineering Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 3.06% CN¥20.05 Million CN¥655.87 Million --
pp = percentage points